Site Index
Home
About Us
Core Values
Leadership Team
Products & Services
Publication Plans
Top Ten Reports
News & Events
Press Releases
In The News
Events
Webinar: Implications of ASCO 2013 on Biosimilar Monoclonal Antibody Market Potential
Analyst Call: Implications of the FDA’s Draft Guidance for Biosimilars
Analyst Call: Highlights from the 11th Annual EGA Biosimilars Symposium
Analyst Call: Highlights from the 4th Annual Biosimilars Asia Conference
Analyst Call: The Impact of Recent Events on the Biosimilar Insulin Opportunity
Analyst Call:Highlights from the 10th Annual EGA Biosimilars Symposium
Webinar: Renal Anemia in Chronic Kidney Disease (CKD): Following the Omontys Recall
Webinar: Approvals and Withdrawals: Implications of Recent Regulatory and Corporate Decisions for Br
Webinar: Japanese Approval of Biosimilar Filgrastim: Further Evidence that 2012 was a Pivotal Year i
Webinar: Commercial Potential for Biosimilars in Oncology Indications: Where is the Opportunity? <i>
Webinar: How Will Payer Influence Impact the Biosimilar Industry?
Webinar: Physician Insights Into the Current Biosimilar ESA Market and How the First Biosimilars Wil
Webinar: Comparing Clinical Data and Physician Expectations of Biosimilar Infliximab: What is the Ma
Webinar: Approval of Teva’s tbo-filgrastim: What Opportunity Remains for ‘True’ Biosimilar Versions
Webinar: Physician Perceptions of Indication Extrapolation for Biosimilars in Immune Diseases <i>-On
Webinar: Physician Perceptions and Market Implications of Automatic Substitution of Branded Biologic
Webinar: Recent Developments in Strategic Partnerships for Biosimilars – What is Important for a Suc
Roundup
Contact Us
Directions - North America
Directions - Europe
Careers
Benefits
Training and Development
Recognition
Job Opportunities
BioTrends RSS Feeds
Search Published Reports
Filter results:
All Therapeutic Areas
Critical Care
Immune & Inflammatory
Infectious Disease
Metabolic Disorders
Nephrology
Neurology
Oncology
Ophthalmology
Other
All Product Lines
Biosimilars Advisory Service
ChartTrends
Critical Insights on Special Topics
LaunchTrends
PatientTrends
Treatment Algorithms
TreatmentTrends
All Industry Topics
Biologics
Emerging Markets
Generics and Biosimilars
Overall Industry Dynamics
Pharmaceutical Industry Dynamics
Primary Research - Patients
Primary Research - Physicians
Strategic Overviews
Therapeutic Markets - Opportunities
All Years
2013
2012
2011
2010
2009
2008
2007
Home
About Us
Products & Services
News & Events
Contact Us
My Products
Decision Resources Group brands include:
Abacus
AMR
BT
DR
FF
HLI
MR
MRG
PS
PINS